Clinical trial
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage…
NCT00301886 · SWOG Cancer Research Network, Other · Withdrawn
Key facts
| NCT number | NCT00301886 |
|---|---|
| Title | S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone |
| Official title | A Phase III Randomized, Multicenter Non-Inferiority Trial Evaluating the Efficacy of Oral Ibandronate Versus Intravenous Zoledronate in the Reduction of Skeletal-Related Events in Patients With Metastatic Breast Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer, Pain |
| Intervention type | Drug, Procedure |
| Interventions | ibandronate, zoledronate, quality-of-life assessment |
| Enrollment | 0 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Mar 13, 2006 |
| Last update posted | Nov 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: